Orai1 contributes to the establishment of an apoptosis-resistant phenotype in prostate cancer cells
The molecular nature of calcium (Ca 2+ )-dependent mechanisms and the ion channels having a major role in the apoptosis of cancer cells remain a subject of debate. Here, we show that the recently identified Orai1 protein represents the major molecular component of endogenous store-operated Ca 2+ ent...
Saved in:
Published in | Cell death & disease Vol. 1; no. 9; p. e75 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
01.09.2010
Springer Nature B.V Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The molecular nature of calcium (Ca
2+
)-dependent mechanisms and the ion channels having a major role in the apoptosis of cancer cells remain a subject of debate. Here, we show that the recently identified Orai1 protein represents the major molecular component of endogenous store-operated Ca
2+
entry (SOCE) in human prostate cancer (PCa) cells, and constitutes the principal source of Ca
2+
influx used by the cell to trigger apoptosis. The downregulation of Orai1, and consequently SOCE, protects the cells from diverse apoptosis-inducing pathways, such as those induced by thapsigargin (Tg), tumor necrosis factor
α
, and cisplatin/oxaliplatin. The transfection of functional Orai1 mutants, such as R91W, a selectivity mutant, and L273S, a coiled-coil mutant, into the cells significantly decreased both SOCE and the rate of Tg-induced apoptosis. This suggests that the functional coupling of STIM1 to Orai1, as well as Orai1 Ca
2+
-selectivity as a channel, is required for its pro-apoptotic effects. We have also shown that the apoptosis resistance of androgen-independent PCa cells is associated with the downregulation of Orai1 expression as well as SOCE. Orai1 rescue, following Orai1 transfection of steroid-deprived cells, re-established the store-operated channel current and restored the normal rate of apoptosis. Thus, Orai1 has a pivotal role in the triggering of apoptosis, irrespective of apoptosis-inducing stimuli, and in the establishment of an apoptosis-resistant phenotype in PCa cells. |
---|---|
AbstractList | The molecular nature of calcium (Ca(2+))-dependent mechanisms and the ion channels having a major role in the apoptosis of cancer cells remain a subject of debate. Here, we show that the recently identified Orai1 protein represents the major molecular component of endogenous store-operated Ca(2+) entry (SOCE) in human prostate cancer (PCa) cells, and constitutes the principal source of Ca(2+) influx used by the cell to trigger apoptosis. The downregulation of Orai1, and consequently SOCE, protects the cells from diverse apoptosis-inducing pathways, such as those induced by thapsigargin (Tg), tumor necrosis factor α, and cisplatin/oxaliplatin. The transfection of functional Orai1 mutants, such as R91W, a selectivity mutant, and L273S, a coiled-coil mutant, into the cells significantly decreased both SOCE and the rate of Tg-induced apoptosis. This suggests that the functional coupling of STIM1 to Orai1, as well as Orai1 Ca(2+)-selectivity as a channel, is required for its pro-apoptotic effects. We have also shown that the apoptosis resistance of androgen-independent PCa cells is associated with the downregulation of Orai1 expression as well as SOCE. Orai1 rescue, following Orai1 transfection of steroid-deprived cells, re-established the store-operated channel current and restored the normal rate of apoptosis. Thus, Orai1 has a pivotal role in the triggering of apoptosis, irrespective of apoptosis-inducing stimuli, and in the establishment of an apoptosis-resistant phenotype in PCa cells. The molecular nature of calcium (Ca2+ )-dependent mechanisms and the ion channels having a major role in the apoptosis of cancer cells remain a subject of debate. Here, we show that the recently identified Orai1 protein represents the major molecular component of endogenous store-operated Ca2+ entry (SOCE) in human prostate cancer (PCa) cells, and constitutes the principal source of Ca2+ influx used by the cell to trigger apoptosis. The downregulation of Orai1, and consequently SOCE, protects the cells from diverse apoptosis-inducing pathways, such as those induced by thapsigargin (Tg), tumor necrosis factor α, and cisplatin/oxaliplatin. The transfection of functional Orai1 mutants, such as R91W, a selectivity mutant, and L273S, a coiled-coil mutant, into the cells significantly decreased both SOCE and the rate of Tg-induced apoptosis. This suggests that the functional coupling of STIM1 to Orai1, as well as Orai1 Ca 2+ -selectivity as a channel, is required for its pro-apoptotic effects. We have also shown that the apoptosis resistance of androgen-independent PCa cells is associated with the downregulation of Orai1 expression as well as SOCE. Orai1 rescue, following Orai1 transfection of steroid-deprived cells, re-established the store-operated channel current and restored the normal rate of apoptosis. Thus, Orai1 has a pivotal role in the triggering of apoptosis, irrespective of apoptosis-inducing stimuli, and in the establishment of an apoptosis-resistant phenotype in PCa cells. The molecular nature of calcium (Ca super(2+))-dependent mechanisms and the ion channels having a major role in the apoptosis of cancer cells remain a subject of debate. Here, we show that the recently identified Orai1 protein represents the major molecular component of endogenous store-operated Ca super(2+) entry (SOCE) in human prostate cancer (PCa) cells, and constitutes the principal source of Ca super(2+) influx used by the cell to trigger apoptosis. The downregulation of Orai1, and consequently SOCE, protects the cells from diverse apoptosis-inducing pathways, such as those induced by thapsigargin (Tg), tumor necrosis factor alpha , and cisplatin/oxaliplatin. The transfection of functional Orai1 mutants, such as R91W, a selectivity mutant, and L273S, a coiled-coil mutant, into the cells significantly decreased both SOCE and the rate of Tg-induced apoptosis. This suggests that the functional coupling of STIM1 to Orai1, as well as Orai1 Ca super(2+)-selectivity as a channel, is required for its pro-apoptotic effects. We have also shown that the apoptosis resistance of androgen-independent PCa cells is associated with the downregulation of Orai1 expression as well as SOCE. Orai1 rescue, following Orai1 transfection of steroid-deprived cells, re-established the store-operated channel current and restored the normal rate of apoptosis. Thus, Orai1 has a pivotal role in the triggering of apoptosis, irrespective of apoptosis-inducing stimuli, and in the establishment of an apoptosis-resistant phenotype in PCa cells. The molecular nature of calcium (Ca 2+ )-dependent mechanisms and the ion channels having a major role in the apoptosis of cancer cells remain a subject of debate. Here, we show that the recently identified Orai1 protein represents the major molecular component of endogenous store-operated Ca 2+ entry (SOCE) in human prostate cancer (PCa) cells, and constitutes the principal source of Ca 2+ influx used by the cell to trigger apoptosis. The downregulation of Orai1, and consequently SOCE, protects the cells from diverse apoptosis-inducing pathways, such as those induced by thapsigargin (Tg), tumor necrosis factor α , and cisplatin/oxaliplatin. The transfection of functional Orai1 mutants, such as R91W, a selectivity mutant, and L273S, a coiled-coil mutant, into the cells significantly decreased both SOCE and the rate of Tg-induced apoptosis. This suggests that the functional coupling of STIM1 to Orai1, as well as Orai1 Ca 2+ -selectivity as a channel, is required for its pro-apoptotic effects. We have also shown that the apoptosis resistance of androgen-independent PCa cells is associated with the downregulation of Orai1 expression as well as SOCE. Orai1 rescue, following Orai1 transfection of steroid-deprived cells, re-established the store-operated channel current and restored the normal rate of apoptosis. Thus, Orai1 has a pivotal role in the triggering of apoptosis, irrespective of apoptosis-inducing stimuli, and in the establishment of an apoptosis-resistant phenotype in PCa cells. The molecular nature of calcium (Ca(2+))-dependent mechanisms and the ion channels having a major role in the apoptosis of cancer cells remain a subject of debate. Here, we show that the recently identified Orai1 protein represents the major molecular component of endogenous store-operated Ca(2+) entry (SOCE) in human prostate cancer (PCa) cells, and constitutes the principal source of Ca(2+) influx used by the cell to trigger apoptosis. The downregulation of Orai1, and consequently SOCE, protects the cells from diverse apoptosis-inducing pathways, such as those induced by thapsigargin (Tg), tumor necrosis factor α, and cisplatin/oxaliplatin. The transfection of functional Orai1 mutants, such as R91W, a selectivity mutant, and L273S, a coiled-coil mutant, into the cells significantly decreased both SOCE and the rate of Tg-induced apoptosis. This suggests that the functional coupling of STIM1 to Orai1, as well as Orai1 Ca(2+)-selectivity as a channel, is required for its pro-apoptotic effects. We have also shown that the apoptosis resistance of androgen-independent PCa cells is associated with the downregulation of Orai1 expression as well as SOCE. Orai1 rescue, following Orai1 transfection of steroid-deprived cells, re-established the store-operated channel current and restored the normal rate of apoptosis. Thus, Orai1 has a pivotal role in the triggering of apoptosis, irrespective of apoptosis-inducing stimuli, and in the establishment of an apoptosis-resistant phenotype in PCa cells.The molecular nature of calcium (Ca(2+))-dependent mechanisms and the ion channels having a major role in the apoptosis of cancer cells remain a subject of debate. Here, we show that the recently identified Orai1 protein represents the major molecular component of endogenous store-operated Ca(2+) entry (SOCE) in human prostate cancer (PCa) cells, and constitutes the principal source of Ca(2+) influx used by the cell to trigger apoptosis. The downregulation of Orai1, and consequently SOCE, protects the cells from diverse apoptosis-inducing pathways, such as those induced by thapsigargin (Tg), tumor necrosis factor α, and cisplatin/oxaliplatin. The transfection of functional Orai1 mutants, such as R91W, a selectivity mutant, and L273S, a coiled-coil mutant, into the cells significantly decreased both SOCE and the rate of Tg-induced apoptosis. This suggests that the functional coupling of STIM1 to Orai1, as well as Orai1 Ca(2+)-selectivity as a channel, is required for its pro-apoptotic effects. We have also shown that the apoptosis resistance of androgen-independent PCa cells is associated with the downregulation of Orai1 expression as well as SOCE. Orai1 rescue, following Orai1 transfection of steroid-deprived cells, re-established the store-operated channel current and restored the normal rate of apoptosis. Thus, Orai1 has a pivotal role in the triggering of apoptosis, irrespective of apoptosis-inducing stimuli, and in the establishment of an apoptosis-resistant phenotype in PCa cells. |
Author | Shuba, Y Lehen'kyi, V Lepage, G Vandenberghe, M Mauroy, B Skryma, R Romanin, C Abeele, F V Roudbaraki, M Raphaël, M Beck, B Flourakis, M Prevarskaya, N |
Author_xml | – sequence: 1 givenname: M surname: Flourakis fullname: Flourakis, M organization: INSERM U1003, Equipe labellisée par la Ligue Nationale contre le cancer, Université des Sciences et Technologies de Lille (USTL), 7Current address: Center for Sleep and Circadian Biology, Department of Neurobiology and Physiology, Northwestern University, 2205 Tech Drive, #2-160, Evanston, IL 60208, USA – sequence: 2 givenname: V surname: Lehen'kyi fullname: Lehen'kyi, V organization: INSERM U1003, Equipe labellisée par la Ligue Nationale contre le cancer, Université des Sciences et Technologies de Lille (USTL) – sequence: 3 givenname: B surname: Beck fullname: Beck, B organization: INSERM U1003, Equipe labellisée par la Ligue Nationale contre le cancer, Université des Sciences et Technologies de Lille (USTL) – sequence: 4 givenname: M surname: Raphaël fullname: Raphaël, M organization: INSERM U1003, Equipe labellisée par la Ligue Nationale contre le cancer, Université des Sciences et Technologies de Lille (USTL) – sequence: 5 givenname: M surname: Vandenberghe fullname: Vandenberghe, M organization: INSERM U1003, Equipe labellisée par la Ligue Nationale contre le cancer, Université des Sciences et Technologies de Lille (USTL) – sequence: 6 givenname: F V surname: Abeele fullname: Abeele, F V organization: INSERM U1003, Equipe labellisée par la Ligue Nationale contre le cancer, Université des Sciences et Technologies de Lille (USTL) – sequence: 7 givenname: M surname: Roudbaraki fullname: Roudbaraki, M organization: INSERM U1003, Equipe labellisée par la Ligue Nationale contre le cancer, Université des Sciences et Technologies de Lille (USTL) – sequence: 8 givenname: G surname: Lepage fullname: Lepage, G organization: INSERM U1003, Equipe labellisée par la Ligue Nationale contre le cancer, Université des Sciences et Technologies de Lille (USTL) – sequence: 9 givenname: B surname: Mauroy fullname: Mauroy, B organization: Université Catholique de Lille, Service d'Urologie – sequence: 10 givenname: C surname: Romanin fullname: Romanin, C organization: Institute for Biophysics, Johannes Kepler Universität Linz – sequence: 11 givenname: Y surname: Shuba fullname: Shuba, Y organization: Bogomoletz Institute of Physiology and International Center of Molecular Physiology NASU – sequence: 12 givenname: R surname: Skryma fullname: Skryma, R organization: INSERM U1003, Equipe labellisée par la Ligue Nationale contre le cancer, Université des Sciences et Technologies de Lille (USTL) – sequence: 13 givenname: N surname: Prevarskaya fullname: Prevarskaya, N email: Natacha.Prevarskaya@univ-lille1.fr organization: INSERM U1003, Equipe labellisée par la Ligue Nationale contre le cancer, Université des Sciences et Technologies de Lille (USTL) |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/21364678$$D View this record in MEDLINE/PubMed https://hal.science/hal-04122793$$DView record in HAL |
BookMark | eNp9kktv1DAQgC1UREvpkSuyxAF6yOLHOnYulaoKWqSVeundcpxJ4yprB9up1H-Pw5ZqWQE--DHzzXheb9GRDx4Qek_JihKuvtiuc2nFSHkL9gqdMLKm1Vqp5mjvfozOUnogZXFOmKjfoGNGeb2upTpB9jYaR7ENPkfXzhkSzgHnATCkbNrRpWELPuPQY-OxmcKUQ3KpilD2bIpmGsCH_DQBdh5PMRRpBmyNtxCxhXFM79Dr3owJzp7PU3T37evd1U21ub3-fnW5qaxgJFctZSBb2nbQ14SBFUSKthbC1EzJHiRrawVgbctkxxTrqGpa2XdSgeo4lfwUXezcTnO7hc6WsKMZ9RTd1sQnHYzTf2q8G_R9eNSccMbXi4PznYPhwOzmcqMXWakoY7Lhj7Swn54_i-HHXGqlty4t2RoPYU5aiZKTJIwU8vN_SSob0tS0Fk1BPx6gD2GOvtSsUKoWvBFMFOrDfp4vkf5uagGqHWBLN1KE_gWhRC9zo3_NjV7mRgtWeH7AW1ea6JaZMG78p9VqZ5WKd38PcS_Yvxr8BCbg12k |
CitedBy_id | crossref_primary_10_1016_j_apsb_2016_11_001 crossref_primary_10_1016_j_bbamem_2014_01_019 crossref_primary_10_3390_toxics6030034 crossref_primary_10_3390_cells11081332 crossref_primary_10_3390_cancers12092351 crossref_primary_10_3892_ol_2016_5469 crossref_primary_10_1371_journal_pone_0177484 crossref_primary_10_1002_jcb_24020 crossref_primary_10_1016_j_tcb_2022_07_004 crossref_primary_10_1016_j_bbamcr_2023_119532 crossref_primary_10_1007_s00424_013_1254_8 crossref_primary_10_1111_1440_1681_12900 crossref_primary_10_1016_j_humpath_2015_09_042 crossref_primary_10_1098_rstb_2013_0097 crossref_primary_10_1042_BSR20110062 crossref_primary_10_1074_jbc_M114_548602 crossref_primary_10_3390_biom11020229 crossref_primary_10_1007_s10059_013_2268_7 crossref_primary_10_1016_j_ceca_2019_102109 crossref_primary_10_18632_aging_100481 crossref_primary_10_1016_j_ceca_2018_09_005 crossref_primary_10_4049_jimmunol_1402942 crossref_primary_10_1038_s41420_019_0212_4 crossref_primary_10_1016_j_bbrc_2014_04_064 crossref_primary_10_4161_chan_24302 crossref_primary_10_1016_j_bbamcr_2014_02_012 crossref_primary_10_1152_physrev_00044_2016 crossref_primary_10_3390_biomedicines8060169 crossref_primary_10_1016_j_ceca_2018_07_011 crossref_primary_10_1371_journal_pone_0086089 crossref_primary_10_1186_s12935_020_01192_0 crossref_primary_10_1016_j_ceca_2019_102061 crossref_primary_10_1556_2060_2021_00137 crossref_primary_10_1096_fj_12_213801 crossref_primary_10_1016_j_ctrv_2013_07_008 crossref_primary_10_1038_onc_2012_481 crossref_primary_10_2147_IJN_S440419 crossref_primary_10_1080_23808993_2020_1803062 crossref_primary_10_3390_ijms23031763 crossref_primary_10_1038_nrc3105 crossref_primary_10_1111_jcmm_17516 crossref_primary_10_1098_rstb_2013_0108 crossref_primary_10_1098_rstb_2013_0109 crossref_primary_10_1016_j_snb_2019_03_084 crossref_primary_10_1016_j_bcp_2023_115955 crossref_primary_10_3390_cells10051246 crossref_primary_10_3390_cancers11070899 crossref_primary_10_1161_ATVBAHA_116_307869 crossref_primary_10_3390_ijms22010004 crossref_primary_10_1074_jbc_M117_796920 crossref_primary_10_3390_cancers15010101 crossref_primary_10_1016_j_bcp_2019_08_005 crossref_primary_10_1007_s11427_014_4774_3 crossref_primary_10_1515_bmc_2022_0012 crossref_primary_10_1096_fj_202002031RR crossref_primary_10_1007_s00285_023_02033_0 crossref_primary_10_1016_j_bbrc_2011_09_081 crossref_primary_10_1074_jbc_R112_343061 crossref_primary_10_1016_j_phrs_2019_104282 crossref_primary_10_3390_cancers11040457 crossref_primary_10_15407_ubj90_03_041 crossref_primary_10_4161_chan_24960 crossref_primary_10_1016_j_bbrc_2019_03_025 crossref_primary_10_3390_cells10050966 crossref_primary_10_1016_j_bbamem_2014_10_030 crossref_primary_10_1016_j_bbrc_2011_09_110 crossref_primary_10_1007_s10571_020_00873_8 crossref_primary_10_1016_j_dci_2019_103601 crossref_primary_10_1517_14728222_2013_741594 crossref_primary_10_1016_j_jbior_2017_11_006 crossref_primary_10_1016_j_molcel_2020_04_017 crossref_primary_10_1016_j_ceca_2017_06_002 crossref_primary_10_3390_cells10061317 crossref_primary_10_1038_s41585_023_00738_x crossref_primary_10_1111_pcmr_12222 crossref_primary_10_3390_cancers13122947 crossref_primary_10_3390_membranes10120425 crossref_primary_10_1016_j_jsbmb_2014_05_006 crossref_primary_10_1152_ajpcell_00064_2015 crossref_primary_10_1152_ajpcell_00364_2015 crossref_primary_10_1038_cddis_2015_23 crossref_primary_10_3390_cells11010057 crossref_primary_10_1007_s12035_018_1112_y crossref_primary_10_3390_cancers11030376 crossref_primary_10_1038_srep11754 crossref_primary_10_3390_ijms19041237 crossref_primary_10_1002_mc_22324 crossref_primary_10_1016_j_ceca_2018_12_003 crossref_primary_10_1002_cam4_2756 crossref_primary_10_1038_s41420_023_01703_8 crossref_primary_10_1080_19420862_2018_1548232 crossref_primary_10_3390_ijms21093218 crossref_primary_10_1152_ajpcell_00249_2011 crossref_primary_10_3390_cancers12030750 crossref_primary_10_1016_j_bpj_2015_08_006 crossref_primary_10_3389_fragi_2022_876785 crossref_primary_10_1111_febs_12246 crossref_primary_10_3389_fphar_2020_00968 crossref_primary_10_3390_ijms23105555 crossref_primary_10_1016_j_ceca_2023_102716 crossref_primary_10_3390_biomedicines9091077 crossref_primary_10_1016_s10059_013_2268_7 crossref_primary_10_1016_j_ceca_2011_04_002 crossref_primary_10_1161_CIRCRESAHA_122_321041 crossref_primary_10_1016_j_ceca_2022_102673 crossref_primary_10_18632_oncotarget_2035 crossref_primary_10_3390_cancers15061825 crossref_primary_10_3390_cells12182225 crossref_primary_10_3390_jpm12020210 crossref_primary_10_1007_s11427_016_5087_5 crossref_primary_10_1016_j_jsps_2022_12_009 crossref_primary_10_1002_ijc_29840 crossref_primary_10_1016_j_ceca_2022_102554 crossref_primary_10_1073_pnas_1218247109 crossref_primary_10_1016_j_bbamcr_2015_10_003 crossref_primary_10_1016_j_canlet_2018_06_006 crossref_primary_10_1016_j_ceca_2013_01_001 crossref_primary_10_1038_cddis_2011_89 crossref_primary_10_3390_cancers10090331 crossref_primary_10_3390_biom14040417 crossref_primary_10_3389_fcell_2020_622215 crossref_primary_10_1038_nrc_2017_18 crossref_primary_10_1039_D1SM01618K crossref_primary_10_1038_cddis_2012_2 crossref_primary_10_3390_ijms231810687 crossref_primary_10_1016_j_bbamcr_2015_12_009 crossref_primary_10_1111_febs_12475 crossref_primary_10_20517_cdr_2023_145 crossref_primary_10_1002_pros_23904 crossref_primary_10_1007_s40610_017_0072_8 crossref_primary_10_5306_wjco_v14_i12_549 crossref_primary_10_1016_j_ccr_2014_04_025 crossref_primary_10_1007_s00249_016_1171_9 crossref_primary_10_3389_fnmol_2021_757515 crossref_primary_10_1002_mc_20843 crossref_primary_10_1152_ajpcell_00136_2011 crossref_primary_10_1073_pnas_1413409111 crossref_primary_10_18632_oncotarget_9755 crossref_primary_10_1016_j_bbamem_2015_06_009 crossref_primary_10_52601_bpr_2024_230023 crossref_primary_10_1186_2193_1801_2_54 crossref_primary_10_1113_JP271141 crossref_primary_10_1089_bioe_2022_0013 crossref_primary_10_1016_j_ceca_2018_03_002 crossref_primary_10_1155_2023_4732242 crossref_primary_10_1038_s41418_017_0007_1 crossref_primary_10_1016_j_bbamcr_2015_11_032 crossref_primary_10_1016_j_bbrc_2016_06_032 crossref_primary_10_1016_j_bbamcr_2015_11_033 crossref_primary_10_1007_s10059_013_0073_2 crossref_primary_10_18632_oncotarget_1903 crossref_primary_10_1002_emmm_201303129 crossref_primary_10_1016_j_gendis_2024_101281 crossref_primary_10_3389_fmolb_2022_1041674 crossref_primary_10_1016_j_coph_2016_03_002 crossref_primary_10_1111_j_1582_4934_2011_01395_x |
Cites_doi | 10.1038/ncb1995 10.1038/onc.2008.308 10.1096/fj.05-5254fje 10.1016/j.ceca.2007.03.007 10.1074/jbc.M708898200 10.1038/ncb1731 10.1038/sj.cdd.4401375 10.1111/j.1469-7793.2000.00071.x 10.1096/fj.09-131128 10.1002/(SICI)1097-0045(199604)28:4<251::AID-PROS6>3.0.CO;2-G 10.1103/PhysRevE.77.016604 10.1074/jbc.M509110200 10.1158/0008-5472.CAN-05-2394 10.1038/ncb1435 10.1074/jbc.M804942200 10.1093/bioinformatics/bti473 10.1002/pros.10133 10.1016/S1535-6108(02)00034-X 10.1038/sj.onc.1210545 10.1126/science.1081208 10.1093/annonc/12.suppl_2.S141 10.1038/nature04147 10.1016/j.ccr.2008.12.019 10.1006/meth.2001.1262 10.1038/cdd.2008.123 10.1074/jbc.M310206200 10.1073/pnas.0611692104 10.1056/NEJMoa040720 10.4161/cbt.4.1.1505 10.1124/mol.59.4.657 10.1016/j.bbrc.2004.08.037 |
ContentType | Journal Article |
Copyright | The Author(s) 2010 Copyright Nature Publishing Group Sep 2010 Distributed under a Creative Commons Attribution 4.0 International License Copyright © 2010 Macmillan Publishers Limited 2010 Macmillan Publishers Limited |
Copyright_xml | – notice: The Author(s) 2010 – notice: Copyright Nature Publishing Group Sep 2010 – notice: Distributed under a Creative Commons Attribution 4.0 International License – notice: Copyright © 2010 Macmillan Publishers Limited 2010 Macmillan Publishers Limited |
DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88A 88I 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M2P M7P PHGZM PHGZT PIMPY PKEHL PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7TO H94 7X8 1XC 5PM |
DOI | 10.1038/cddis.2010.52 |
DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Science Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences Health & Medical Collection (Alumni) Science Database Biological Science Database ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic Oncogenes and Growth Factors Abstracts AIDS and Cancer Research Abstracts MEDLINE - Academic Hyper Article en Ligne (HAL) PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Central China ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest One Applied & Life Sciences Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Central (New) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) Oncogenes and Growth Factors Abstracts AIDS and Cancer Research Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE Publicly Available Content Database Oncogenes and Growth Factors Abstracts MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
DocumentTitleAlternate | Orai1 in apoptosis resistance of prostate cancer |
EISSN | 2041-4889 |
EndPage | e75 |
ExternalDocumentID | PMC3032347 oai_HAL_hal_04122793v1 4043799051 21364678 10_1038_cddis_2010_52 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- 0R~ 3V. 53G 5VS 70F 7X7 88A 88I 8FE 8FH 8FI 8FJ AAJSJ ABAWZ ABUWG ACGFS ACSMW ADBBV ADRAZ AENEX AFKRA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI C6C CAG CCPQU COF DIK DWQXO E3Z EBLON EBS EJD EMOBN FRP FYUFA GNUQQ GROUPED_DOAJ HCIFZ HMCUK HYE HZ~ IPNFZ KQ8 LK8 M0L M2P M48 M7P M~E NAO O5R O5S O9- OK1 PIMPY PQQKQ PROAC RIG RNT RPM SNYQT TR2 UKHRP W2D AASML AAYXX CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM 7XB 8FK AARCD K9. PKEHL PQEST PQGLB PQUKI PRINS Q9U 7TO H94 7X8 1XC 5PM |
ID | FETCH-LOGICAL-c520t-b12e7b1bdef602ec5075b655a6287fe72b68eeccb27d282d189b7fd78e8d3173 |
IEDL.DBID | M48 |
ISSN | 2041-4889 |
IngestDate | Thu Aug 21 14:05:31 EDT 2025 Fri May 09 12:26:28 EDT 2025 Thu Jul 10 19:22:19 EDT 2025 Fri Jul 11 11:00:25 EDT 2025 Wed Aug 13 03:12:32 EDT 2025 Thu Jan 02 22:08:15 EST 2025 Tue Jul 01 01:10:32 EDT 2025 Thu Apr 24 23:12:39 EDT 2025 Fri Feb 21 02:37:08 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 9 |
Keywords | prostate cancer apoptosis resistance Orai channels store-operated calcium entry |
Language | English |
License | Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0 This work is licensed under the Creative Commons Attribution-NonCommercial-No Derivative Works 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c520t-b12e7b1bdef602ec5075b655a6287fe72b68eeccb27d282d189b7fd78e8d3173 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 PMCID: PMC3032347 These authors contributed equally to this work. Current address: Center for Sleep and Circadian Biology, Department of Neurobiology and Physiology, Northwestern University, 2205 Tech Drive, #2-160, Evanston, IL 60208, USA. |
OpenAccessLink | https://www.proquest.com/docview/1786539525?pq-origsite=%requestingapplication% |
PMID | 21364678 |
PQID | 1786539525 |
PQPubID | 2041963 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3032347 hal_primary_oai_HAL_hal_04122793v1 proquest_miscellaneous_855207020 proquest_miscellaneous_1790961659 proquest_journals_1786539525 pubmed_primary_21364678 crossref_primary_10_1038_cddis_2010_52 crossref_citationtrail_10_1038_cddis_2010_52 springer_journals_10_1038_cddis_2010_52 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2010-09-01 |
PublicationDateYYYYMMDD | 2010-09-01 |
PublicationDate_xml | – month: 09 year: 2010 text: 2010-09-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | Cell death & disease |
PublicationTitleAbbrev | Cell Death Dis |
PublicationTitleAlternate | Cell Death Dis |
PublicationYear | 2010 |
Publisher | Nature Publishing Group UK Springer Nature B.V Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group UK – name: Springer Nature B.V – name: Nature Publishing Group |
References | Denmeade, Lin, Isaacs (CR18) 1996; 28 Smyth, Petranka, Boyles, DeHaven, Fukushima, Johnson (CR30) 2009; 11 Denmeade, Isaacs (CR22) 2005; 4 Muik, Frischauf, Derler, Fahrner, Bergsmann, Eder (CR12) 2008; 283 Livak, Schmittgen (CR32) 2001; 25 Gwack, Feske, Srikanth, Hogan, Rao (CR16) 2007; 42 Yang, Zhang, Huang (CR28) 2009; 15 Vanden Abeele, Skryma, Shuba, Van Coppenolle, Slomianny, Roudbaraki (CR14) 2002; 1 Fixemer, Remberger, Bonkhoff (CR5) 2002; 53 Bonkhoff (CR19) 2001; 12 Peinelt, Vig, Koomoa, Beck, Nadler, Koblan-Huberson (CR27) 2006; 8 Zhang, Yu, Roos, Kozak, Deerinck, Ellisman (CR10) 2005; 437 Vanoverberghe, Vanden Abeele, Mariot, Lepage, Roudbaraki, Bonnal (CR9) 2004; 11 Potier, Gonzalez, Motiani, Abdullaev, Bisaillon, Singer (CR29) 2009; 23 Norberg, Gogvadze, Ott, Horn, Uhlen, Orrenius (CR4) 2008; 15 Raffo, Perlman, Chen, Day, Streitman, Buttyan (CR6) 1995; 55 Nawrocki, Carew, Dunner, Boise, Chiao, Huang (CR25) 2005; 65 Gonzalez, Fuertes, Alonso, Perez (CR23) 2001; 59 Skryma, Mariot, Bourhis, Coppenolle, Shuba, Vanden Abeele (CR8) 2000; 527 Di Sano, Ferraro, Tufi, Achsel, Piacentini, Cecconi (CR24) 2006; 281 Nantermet, Xu, Yu, Hodor, Holder, Adamski (CR20) 2004; 279 Scorrano, Oakes, Opferman, Cheng, Sorcinelli, Pozzan (CR1) 2003; 300 Cartharius, Frech, Grote, Klocke, Haltmeier, Klingenhoff (CR21) 2005; 21 Prevarskaya, Skryma, Shuba (CR2) 2004; 322 Ng, di Capite, Singaravelu, Parekh (CR13) 2008; 283 Stiber, Hawkins, Zhang, Wang, Burch, Graham (CR17) 2008; 10 Lehen'kyi, Flourakis, Skryma, Prevarskaya (CR31) 2007; 26 Flourakis, Van Coppenolle, Lehen'kyi, Beck, Skryma, Prevarskaya (CR26) 2006; 20 Pinton, Giorgi, Siviero, Zecchini, Rizzuto (CR3) 2008; 27 Tannock, de Wit, Berry, Horti, Pluzanska, Chi (CR7) 2004; 351 Liao, Erxleben, Yildirim, Abramowitz, Armstrong, Birnbaumer (CR11) 2007; 104 Abdullaev, Bludov, Dmitriev, Kevrekidis, Konotop (CR15) 2008; 77 L Scorrano (BFcddis201052_CR1) 2003; 300 Y Gwack (BFcddis201052_CR16) 2007; 42 SR Denmeade (BFcddis201052_CR18) 1996; 28 KJ Livak (BFcddis201052_CR32) 2001; 25 V Lehen'kyi (BFcddis201052_CR31) 2007; 26 P Pinton (BFcddis201052_CR3) 2008; 27 F Vanden Abeele (BFcddis201052_CR14) 2002; 1 SR Denmeade (BFcddis201052_CR22) 2005; 4 C Peinelt (BFcddis201052_CR27) 2006; 8 SW Ng (BFcddis201052_CR13) 2008; 283 H Bonkhoff (BFcddis201052_CR19) 2001; 12 J Stiber (BFcddis201052_CR17) 2008; 10 E Norberg (BFcddis201052_CR4) 2008; 15 SL Zhang (BFcddis201052_CR10) 2005; 437 R Skryma (BFcddis201052_CR8) 2000; 527 M Potier (BFcddis201052_CR29) 2009; 23 N Prevarskaya (BFcddis201052_CR2) 2004; 322 Y Liao (BFcddis201052_CR11) 2007; 104 K Cartharius (BFcddis201052_CR21) 2005; 21 T Fixemer (BFcddis201052_CR5) 2002; 53 K Vanoverberghe (BFcddis201052_CR9) 2004; 11 F Di Sano (BFcddis201052_CR24) 2006; 281 PV Nantermet (BFcddis201052_CR20) 2004; 279 VM Gonzalez (BFcddis201052_CR23) 2001; 59 F Abdullaev (BFcddis201052_CR15) 2008; 77 JT Smyth (BFcddis201052_CR30) 2009; 11 M Muik (BFcddis201052_CR12) 2008; 283 AJ Raffo (BFcddis201052_CR6) 1995; 55 S Yang (BFcddis201052_CR28) 2009; 15 IF Tannock (BFcddis201052_CR7) 2004; 351 ST Nawrocki (BFcddis201052_CR25) 2005; 65 M Flourakis (BFcddis201052_CR26) 2006; 20 19364762 - FASEB J. 2009 Aug;23(8):2425-37 15662118 - Cancer Biol Ther. 2005 Jan;4(1):14-22 17360584 - Proc Natl Acad Sci U S A. 2007 Mar 13;104(11):4682-7 18955969 - Oncogene. 2008 Oct 27;27(50):6407-18 18806259 - J Biol Chem. 2008 Nov 14;283(46):31348-55 12242726 - Prostate. 2002 Oct 1;53(2):118-23 14576152 - J Biol Chem. 2004 Jan 9;279(2):1310-22 16611832 - FASEB J. 2006 Jun;20(8):1215-7 8602401 - Prostate. 1996 Apr;28(4):251-65 10944171 - J Physiol. 2000 Aug 15;527 Pt 1:71-83 18187424 - J Biol Chem. 2008 Mar 21;283(12):8014-22 11846609 - Methods. 2001 Dec;25(4):402-8 12086875 - Cancer Cell. 2002 Mar;1(2):169-79 14685164 - Cell Death Differ. 2004 Mar;11(3):321-30 17533368 - Oncogene. 2007 Nov 15;26(52):7380-5 16357160 - Cancer Res. 2005 Dec 15;65(24):11510-9 11259608 - Mol Pharmacol. 2001 Apr;59(4):657-63 15860560 - Bioinformatics. 2005 Jul 1;21(13):2933-42 18488020 - Nat Cell Biol. 2008 Jun;10(6):688-97 17572487 - Cell Calcium. 2007 Aug;42(2):145-56 19185847 - Cancer Cell. 2009 Feb 3;15(2):124-34 18806756 - Cell Death Differ. 2008 Dec;15(12):1857-64 16317003 - J Biol Chem. 2006 Feb 3;281(5):2693-700 11762342 - Ann Oncol. 2001;12 Suppl 2:S141-4 15336979 - Biochem Biophys Res Commun. 2004 Oct 1;322(4):1326-35 16733527 - Nat Cell Biol. 2006 Jul;8(7):771-3 19881501 - Nat Cell Biol. 2009 Dec;11(12):1465-72 16208375 - Nature. 2005 Oct 6;437(7060):902-5 18351948 - Phys Rev E Stat Nonlin Soft Matter Phys. 2008 Jan;77(1 Pt 2):016604 7671257 - Cancer Res. 1995 Oct 1;55(19):4438-45 15470213 - N Engl J Med. 2004 Oct 7;351(15):1502-12 12624178 - Science. 2003 Apr 4;300(5616):135-9 |
References_xml | – volume: 11 start-page: 1465 year: 2009 end-page: 1472 ident: CR30 article-title: Phosphorylation of STIM1 underlies suppression of store-operated calcium entry during mitosis publication-title: Nat Cell Biol doi: 10.1038/ncb1995 – volume: 27 start-page: 6407 year: 2008 end-page: 6418 ident: CR3 article-title: Calcium and apoptosis: ER-mitochondria Ca2+ transfer in the control of apoptosis publication-title: Oncogene doi: 10.1038/onc.2008.308 – volume: 20 start-page: 1215 year: 2006 end-page: 1217 ident: CR26 article-title: Passive calcium leak via translocon is a first step for iPLA2-pathway regulated store operated channels activation publication-title: FASEB J doi: 10.1096/fj.05-5254fje – volume: 42 start-page: 145 year: 2007 end-page: 156 ident: CR16 article-title: Signalling to transcription: store-operated Ca(2+) entry and NFAT activation in lymphocytes publication-title: Cell Calcium doi: 10.1016/j.ceca.2007.03.007 – volume: 283 start-page: 8014 year: 2008 end-page: 8022 ident: CR12 article-title: Dynamic coupling of the putative coiled-coil domain of ORAI1 with STIM1 mediates ORAI1 channel activation publication-title: J Biol Chem doi: 10.1074/jbc.M708898200 – volume: 10 start-page: 688 year: 2008 end-page: 697 ident: CR17 article-title: STIM1 signalling controls store-operated calcium entry required for development and contractile function in skeletal muscle publication-title: Nat Cell Biol doi: 10.1038/ncb1731 – volume: 11 start-page: 321 year: 2004 end-page: 330 ident: CR9 article-title: Ca2+ homeostasis and apoptotic resistance of neuroendocrine-differentiated prostate cancer cells publication-title: Cell Death Differ doi: 10.1038/sj.cdd.4401375 – volume: 527 start-page: 71 issue: Pt 1 year: 2000 end-page: 83 ident: CR8 article-title: Store depletion and store-operated Ca2+ current in human prostate cancer LNCaP cells: involvement in apoptosis publication-title: J Physiol doi: 10.1111/j.1469-7793.2000.00071.x – volume: 23 start-page: 2425 year: 2009 end-page: 2437 ident: CR29 article-title: Evidence for STIM1- and Orai1-dependent store-operated calcium influx through ICRAC in vascular smooth muscle cells: role in proliferation and migration publication-title: FASEB J doi: 10.1096/fj.09-131128 – volume: 55 start-page: 4438 year: 1995 end-page: 4445 ident: CR6 article-title: Overexpression of bcl-2 protects prostate cancer cells from apoptosis and confers resistance to androgen depletion publication-title: Cancer Res – volume: 28 start-page: 251 year: 1996 end-page: 265 ident: CR18 article-title: Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer publication-title: Prostate doi: 10.1002/(SICI)1097-0045(199604)28:4<251::AID-PROS6>3.0.CO;2-G – volume: 77 start-page: 016604 issue: Pt 2 year: 2008 ident: CR15 article-title: Generalized neighbor-interaction models induced by nonlinear lattices publication-title: Phys Rev E Stat Nonlin Soft Matter Phys doi: 10.1103/PhysRevE.77.016604 – volume: 281 start-page: 2693 year: 2006 end-page: 2700 ident: CR24 article-title: Endoplasmic reticulum stress induces apoptosis by an apoptosome-dependent but caspase 12-independent mechanism publication-title: J Biol Chem doi: 10.1074/jbc.M509110200 – volume: 65 start-page: 11510 year: 2005 end-page: 11519 ident: CR25 article-title: Bortezomib inhibits PKR-like endoplasmic reticulum (ER) kinase and induces apoptosis via ER stress in human pancreatic cancer cells publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-05-2394 – volume: 8 start-page: 771 year: 2006 end-page: 773 ident: CR27 article-title: Amplification of CRAC current by STIM1 and CRACM1 (Orai1) publication-title: Nat Cell Biol doi: 10.1038/ncb1435 – volume: 283 start-page: 31348 year: 2008 end-page: 31355 ident: CR13 article-title: Sustained activation of the tyrosine kinase Syk by antigen in mast cells requires local Ca2+ influx through Ca2+ release-activated Ca2+ channels publication-title: J Biol Chem doi: 10.1074/jbc.M804942200 – volume: 21 start-page: 2933 year: 2005 end-page: 2942 ident: CR21 article-title: MatInspector and beyond: promoter analysis based on transcription factor binding sites publication-title: Bioinformatics doi: 10.1093/bioinformatics/bti473 – volume: 53 start-page: 118 year: 2002 end-page: 123 ident: CR5 article-title: Apoptosis resistance of neuroendocrine phenotypes in prostatic adenocarcinoma publication-title: Prostate doi: 10.1002/pros.10133 – volume: 1 start-page: 169 year: 2002 end-page: 179 ident: CR14 article-title: Bcl-2-dependent modulation of Ca(2+) homeostasis and store-operated channels in prostate cancer cells publication-title: Cancer Cell doi: 10.1016/S1535-6108(02)00034-X – volume: 26 start-page: 7380 year: 2007 end-page: 7385 ident: CR31 article-title: TRPV6 channel controls prostate cancer cell proliferation via Ca(2+)/NFAT-dependent pathways publication-title: Oncogene doi: 10.1038/sj.onc.1210545 – volume: 300 start-page: 135 year: 2003 end-page: 139 ident: CR1 article-title: BAX and BAK regulation of endoplasmic reticulum Ca2+: a control point for apoptosis publication-title: Science doi: 10.1126/science.1081208 – volume: 12 start-page: S141 year: 2001 end-page: S144 ident: CR19 article-title: Neuroendocrine differentiation in human prostate cancer. Morphogenesis, proliferation and androgen receptor status publication-title: Ann Oncol doi: 10.1093/annonc/12.suppl_2.S141 – volume: 437 start-page: 902 year: 2005 end-page: 905 ident: CR10 article-title: STIM1 is a Ca2+ sensor that activates CRAC channels and migrates from the Ca2+ store to the plasma membrane publication-title: Nature doi: 10.1038/nature04147 – volume: 15 start-page: 124 year: 2009 end-page: 134 ident: CR28 article-title: Orai1 and STIM1 are critical for breast tumor cell migration and metastasis publication-title: Cancer Cell doi: 10.1016/j.ccr.2008.12.019 – volume: 25 start-page: 402 year: 2001 end-page: 408 ident: CR32 article-title: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method publication-title: Methods doi: 10.1006/meth.2001.1262 – volume: 15 start-page: 1857 year: 2008 end-page: 1864 ident: CR4 article-title: An increase in intracellular Ca2+ is required for the activation of mitochondrial calpain to release AIF during cell death publication-title: Cell Death Differ doi: 10.1038/cdd.2008.123 – volume: 279 start-page: 1310 year: 2004 end-page: 1322 ident: CR20 article-title: Identification of genetic pathways activated by the androgen receptor during the induction of proliferation in the ventral prostate gland publication-title: J Biol Chem doi: 10.1074/jbc.M310206200 – volume: 104 start-page: 4682 year: 2007 end-page: 4687 ident: CR11 article-title: Orai proteins interact with TRPC channels and confer responsiveness to store depletion publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0611692104 – volume: 351 start-page: 1502 year: 2004 end-page: 1512 ident: CR7 article-title: Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer publication-title: N Engl J Med doi: 10.1056/NEJMoa040720 – volume: 4 start-page: 14 year: 2005 end-page: 22 ident: CR22 article-title: The SERCA pump as a therapeutic target: making a ‘smart bomb’ for prostate cancer publication-title: Cancer Biol Ther doi: 10.4161/cbt.4.1.1505 – volume: 59 start-page: 657 year: 2001 end-page: 663 ident: CR23 article-title: Is cisplatin-induced cell death always produced by apoptosis? publication-title: Mol Pharmacol doi: 10.1124/mol.59.4.657 – volume: 322 start-page: 1326 year: 2004 end-page: 1335 ident: CR2 article-title: Ca2+ homeostasis in apoptotic resistance of prostate cancer cells publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2004.08.037 – volume: 53 start-page: 118 year: 2002 ident: BFcddis201052_CR5 publication-title: Prostate doi: 10.1002/pros.10133 – volume: 15 start-page: 1857 year: 2008 ident: BFcddis201052_CR4 publication-title: Cell Death Differ doi: 10.1038/cdd.2008.123 – volume: 23 start-page: 2425 year: 2009 ident: BFcddis201052_CR29 publication-title: FASEB J doi: 10.1096/fj.09-131128 – volume: 20 start-page: 1215 year: 2006 ident: BFcddis201052_CR26 publication-title: FASEB J doi: 10.1096/fj.05-5254fje – volume: 25 start-page: 402 year: 2001 ident: BFcddis201052_CR32 publication-title: Methods doi: 10.1006/meth.2001.1262 – volume: 283 start-page: 31348 year: 2008 ident: BFcddis201052_CR13 publication-title: J Biol Chem doi: 10.1074/jbc.M804942200 – volume: 1 start-page: 169 year: 2002 ident: BFcddis201052_CR14 publication-title: Cancer Cell doi: 10.1016/S1535-6108(02)00034-X – volume: 527 start-page: 71 issue: Pt 1 year: 2000 ident: BFcddis201052_CR8 publication-title: J Physiol doi: 10.1111/j.1469-7793.2000.00071.x – volume: 279 start-page: 1310 year: 2004 ident: BFcddis201052_CR20 publication-title: J Biol Chem doi: 10.1074/jbc.M310206200 – volume: 4 start-page: 14 year: 2005 ident: BFcddis201052_CR22 publication-title: Cancer Biol Ther doi: 10.4161/cbt.4.1.1505 – volume: 15 start-page: 124 year: 2009 ident: BFcddis201052_CR28 publication-title: Cancer Cell doi: 10.1016/j.ccr.2008.12.019 – volume: 104 start-page: 4682 year: 2007 ident: BFcddis201052_CR11 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0611692104 – volume: 21 start-page: 2933 year: 2005 ident: BFcddis201052_CR21 publication-title: Bioinformatics doi: 10.1093/bioinformatics/bti473 – volume: 11 start-page: 1465 year: 2009 ident: BFcddis201052_CR30 publication-title: Nat Cell Biol doi: 10.1038/ncb1995 – volume: 10 start-page: 688 year: 2008 ident: BFcddis201052_CR17 publication-title: Nat Cell Biol doi: 10.1038/ncb1731 – volume: 12 start-page: S141 year: 2001 ident: BFcddis201052_CR19 publication-title: Ann Oncol doi: 10.1093/annonc/12.suppl_2.S141 – volume: 300 start-page: 135 year: 2003 ident: BFcddis201052_CR1 publication-title: Science doi: 10.1126/science.1081208 – volume: 77 start-page: 016604 issue: Pt 2 year: 2008 ident: BFcddis201052_CR15 publication-title: Phys Rev E Stat Nonlin Soft Matter Phys doi: 10.1103/PhysRevE.77.016604 – volume: 59 start-page: 657 year: 2001 ident: BFcddis201052_CR23 publication-title: Mol Pharmacol doi: 10.1124/mol.59.4.657 – volume: 351 start-page: 1502 year: 2004 ident: BFcddis201052_CR7 publication-title: N Engl J Med doi: 10.1056/NEJMoa040720 – volume: 11 start-page: 321 year: 2004 ident: BFcddis201052_CR9 publication-title: Cell Death Differ doi: 10.1038/sj.cdd.4401375 – volume: 322 start-page: 1326 year: 2004 ident: BFcddis201052_CR2 publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2004.08.037 – volume: 65 start-page: 11510 year: 2005 ident: BFcddis201052_CR25 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-05-2394 – volume: 27 start-page: 6407 year: 2008 ident: BFcddis201052_CR3 publication-title: Oncogene doi: 10.1038/onc.2008.308 – volume: 437 start-page: 902 year: 2005 ident: BFcddis201052_CR10 publication-title: Nature doi: 10.1038/nature04147 – volume: 281 start-page: 2693 year: 2006 ident: BFcddis201052_CR24 publication-title: J Biol Chem doi: 10.1074/jbc.M509110200 – volume: 26 start-page: 7380 year: 2007 ident: BFcddis201052_CR31 publication-title: Oncogene doi: 10.1038/sj.onc.1210545 – volume: 55 start-page: 4438 year: 1995 ident: BFcddis201052_CR6 publication-title: Cancer Res – volume: 28 start-page: 251 year: 1996 ident: BFcddis201052_CR18 publication-title: Prostate doi: 10.1002/(SICI)1097-0045(199604)28:4<251::AID-PROS6>3.0.CO;2-G – volume: 42 start-page: 145 year: 2007 ident: BFcddis201052_CR16 publication-title: Cell Calcium doi: 10.1016/j.ceca.2007.03.007 – volume: 283 start-page: 8014 year: 2008 ident: BFcddis201052_CR12 publication-title: J Biol Chem doi: 10.1074/jbc.M708898200 – volume: 8 start-page: 771 year: 2006 ident: BFcddis201052_CR27 publication-title: Nat Cell Biol doi: 10.1038/ncb1435 – reference: 16208375 - Nature. 2005 Oct 6;437(7060):902-5 – reference: 15336979 - Biochem Biophys Res Commun. 2004 Oct 1;322(4):1326-35 – reference: 16733527 - Nat Cell Biol. 2006 Jul;8(7):771-3 – reference: 17533368 - Oncogene. 2007 Nov 15;26(52):7380-5 – reference: 18955969 - Oncogene. 2008 Oct 27;27(50):6407-18 – reference: 15470213 - N Engl J Med. 2004 Oct 7;351(15):1502-12 – reference: 18187424 - J Biol Chem. 2008 Mar 21;283(12):8014-22 – reference: 14576152 - J Biol Chem. 2004 Jan 9;279(2):1310-22 – reference: 17360584 - Proc Natl Acad Sci U S A. 2007 Mar 13;104(11):4682-7 – reference: 15860560 - Bioinformatics. 2005 Jul 1;21(13):2933-42 – reference: 17572487 - Cell Calcium. 2007 Aug;42(2):145-56 – reference: 11846609 - Methods. 2001 Dec;25(4):402-8 – reference: 16611832 - FASEB J. 2006 Jun;20(8):1215-7 – reference: 16357160 - Cancer Res. 2005 Dec 15;65(24):11510-9 – reference: 18806756 - Cell Death Differ. 2008 Dec;15(12):1857-64 – reference: 12242726 - Prostate. 2002 Oct 1;53(2):118-23 – reference: 14685164 - Cell Death Differ. 2004 Mar;11(3):321-30 – reference: 18488020 - Nat Cell Biol. 2008 Jun;10(6):688-97 – reference: 18351948 - Phys Rev E Stat Nonlin Soft Matter Phys. 2008 Jan;77(1 Pt 2):016604 – reference: 19185847 - Cancer Cell. 2009 Feb 3;15(2):124-34 – reference: 11259608 - Mol Pharmacol. 2001 Apr;59(4):657-63 – reference: 8602401 - Prostate. 1996 Apr;28(4):251-65 – reference: 15662118 - Cancer Biol Ther. 2005 Jan;4(1):14-22 – reference: 19364762 - FASEB J. 2009 Aug;23(8):2425-37 – reference: 12086875 - Cancer Cell. 2002 Mar;1(2):169-79 – reference: 7671257 - Cancer Res. 1995 Oct 1;55(19):4438-45 – reference: 10944171 - J Physiol. 2000 Aug 15;527 Pt 1:71-83 – reference: 16317003 - J Biol Chem. 2006 Feb 3;281(5):2693-700 – reference: 18806259 - J Biol Chem. 2008 Nov 14;283(46):31348-55 – reference: 11762342 - Ann Oncol. 2001;12 Suppl 2:S141-4 – reference: 19881501 - Nat Cell Biol. 2009 Dec;11(12):1465-72 – reference: 12624178 - Science. 2003 Apr 4;300(5616):135-9 |
SSID | ssj0000330256 |
Score | 2.3560197 |
Snippet | The molecular nature of calcium (Ca
2+
)-dependent mechanisms and the ion channels having a major role in the apoptosis of cancer cells remain a subject of... The molecular nature of calcium (Ca(2+))-dependent mechanisms and the ion channels having a major role in the apoptosis of cancer cells remain a subject of... The molecular nature of calcium (Ca2+ )-dependent mechanisms and the ion channels having a major role in the apoptosis of cancer cells remain a subject of... The molecular nature of calcium (Ca super(2+))-dependent mechanisms and the ion channels having a major role in the apoptosis of cancer cells remain a subject... |
SourceID | pubmedcentral hal proquest pubmed crossref springer |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | e75 |
SubjectTerms | 631/45/269/1146 631/80/304 631/80/82/23 692/699/67/589/466 Amino Acid Substitution Antibodies Antineoplastic Agents - therapeutic use Apoptosis Biochemistry Biomedical and Life Sciences Calcium - metabolism Calcium Channels - genetics Calcium Channels - metabolism Calcium Channels - physiology Cell Biology Cell Culture Cell Line, Tumor Cisplatin - therapeutic use Humans Immunology Life Sciences Male Membrane Proteins - metabolism Mutation Neoplasm Proteins - metabolism ORAI1 Protein Original original-article Phenotype Prostatic Neoplasms - drug therapy Prostatic Neoplasms - metabolism Stromal Interaction Molecule 1 Thapsigargin - therapeutic use Tumor Necrosis Factor-alpha - therapeutic use |
SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ba9VAEB5speCLqPUSrbItYl8MTTbZS56kiOUgtr5UOG9hb6EHJIknqeC_dybJST3W-podyGZndufbmS8zAG-tN9r4okDjNTzObW4ov1vEJnDpqoy6wFG84_xCLr7ln5diOQXcuolWuTkTh4PaN45i5Cep0lRFVXDxof0RU9coyq5OLTR24D6VLiOrVks1x1gSvKyjS59KayaZPnFE0hkJXYJvuaKdKyJC3kaZt8mSf2VMB0d09ggeTgiSnY4qfwz3Qv0E9saekr_2wX1dm1XKBgo69bIKHesbhjCP4fvMEHOigCBrKmZqZtqm7Ztu1cV47SYoiSPE-mooNMtWNWvprxDEo8yReawZBfq7p3B59uny4yKeOinETvCkj23Kg7Kp9aGSCQ8OQaCwUggj8cJUBcWt1AGVabnyeAfzqS6sqrzSQXsEGNkz2K2bOrwAJrnzQQVrnLK5D8ZqYZRDFGild0XCI3i_WdPSTVXGqdnF93LIdme6HFRQkgpKgeLvZvF2LK9xl-ARKmiWoaLYi9MvJT2jimEcj5mfaQQHG_2V01bsyhvDieBwHsZNRAtm6tBck0xBrW-kKCJgd8hogUupEF1H8Hy0iHk2PM0kOhwdgdqyla3pbo_Uq6uhljciCJ7lKoLjjVX9MfN_LcTL_3_jK3gw8huIBXcAu_36OrxG2NTbN8Pe-A2Q5xt2 priority: 102 providerName: ProQuest – databaseName: Springer Nature HAS Fully OA dbid: AAJSJ link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1ba9VAEB5qi-CLWOslvchaRF8MJpvsJY8HsRwOVR-s0Lewt9ADkhxOUsF_70ySE4y14Gt2Qpad2d1vZ798A_DGeqONLwoMXsPj3OaG7neL2AQuXZVRFTjKd3z-Ipff89W1uB5_Vm9HWuUgadkv0zt22AdH7JqBiSVwxT0glXYM64PFYvVtNSVVEjyd4x4-amkmmZ6_N9t7HtwQ8_EurLzLjvzrirTfeS6ewOMRMrLF0MlD2Av1U3g4FJH8dQTu69asU9Zzzql4VWhZ1zDEdQy_Z_okE2UAWVMxUzOzaTZd067bGM_ZhB2xhWheDeVi2bpmG_oNBAEocxQPW0aZ_fYZXF18uvq4jMfSCbETPOlim_KgbGp9qGTCg0PUJ6wUwkg8IVVBcSt1QO9ZrjweunyqC6sqr3TQHhFF9hz266YOL4FJ7nxQwRqnbO6DsVoY5RD2WeldkfAI3u_GtHSjrDhVt_hR9tfbmS57F5TkglKg-dvJfDPoadxneI4OmmxIBXu5uCzpGUmEcVxXfqYRnO78V45zry1TpUlvV3ARweupGWcNDZipQ3NLNgXVupGiiIDdY6MFDqVCOB3BiyEipt7wNJO4w-gI1CxWZt2dt9Trm168GyEDz3IVwbtdVP3R838NxPF_W57Ao4HbQAy4U9jvtrfhDCFTZ1-NE-U38XMZxw priority: 102 providerName: Springer Nature |
Title | Orai1 contributes to the establishment of an apoptosis-resistant phenotype in prostate cancer cells |
URI | https://link.springer.com/article/10.1038/cddis.2010.52 https://www.ncbi.nlm.nih.gov/pubmed/21364678 https://www.proquest.com/docview/1786539525 https://www.proquest.com/docview/1790961659 https://www.proquest.com/docview/855207020 https://hal.science/hal-04122793 https://pubmed.ncbi.nlm.nih.gov/PMC3032347 |
Volume | 1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3da9RAEF9si-CL-G20HquIvhh72WQ_8iByHi3HYatoC_cW9iv0oCTnJRX73zuzyZ2e14JPB9kht8zM7v5mdvIbQl4bp5V2eQ7Oq1mcmUzj_W4ea8-ELVPsAof5juMTMTnLpjM--0Mp1CuwuTa0w35SZ8uL979-XH2EBf-h-2RcHVisvOmqtDjsxntwKElsZnDcI_2wKUPczkIvVzbMIGpSKu8ZN7feEPiBUwE7iNo4rHbOsVRyG4dul1P-c6cajqqje-RujzHpqHOK--SWrx6Q213XyauHxH5Z6nlCQ5E6drvyDW1rCkCQwv_pkJXClCGtS6orqhf1oq2beRNDYI5gE0awLqzG5C2dV3SB340AYqUWHWhJ8SqgeUROjw5Px5O477UQW86GbWwS5qVJjPOlGDJvASZyIzjXAkKq0ktmhPJgbsOkgyjNJSo3snRSeeUAgqSPyW5VV_4poYJZ56U32kqTOa-N4lpawIlGOJsPWUTerXRa2J6HHNthXBThPjxVRbBGgdYoOIi_WYsvOgKOmwRfgYHWMkibPRl9LvAZcoox2Ih-JhHZX9mvWPlakUiFBL2c8Yi8XA_DMkOF6crXlyiTY3McwfOI0BtkFAdVSsDfEXnSecR6NiuHiojc8JWN6W6OVPPzwPYNGIOlmYzI25VX_TXz6xTx7H8U8Zzc6eogsFpun-y2y0v_AuBVawZkR87kgOyNRtPvU_j9dHjy9Rs8HYvxIKQsBmFp_QadPyml |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB61RQguiDeGAgviccGqvc561weEKqBKaVouQcrN2pfVSJWdxi6oP4r_yIwfgVDKrdfsyFnPzO588_AMwCvjtNIuy1B5NQ9HZqQpv5uF2vPUFglNgaN4x-FROv42-jITsw34OXwLQ2WVw53YXtSushQj34mloi6qgosPi9OQpkZRdnUYodGpxYE__4EuW_1-_xPK9zXne5-nH8dhP1UgtIJHTWhi7qWJjfNFGnFvERAJkwqhU3QeCi-5SZXHFzNcOvRHXKwyIwsnlVcOjW2Cj92Ea2h3I_L15EyuQjpRkhCC6Dt5RonasVQT1NWPCb5m-TaPqe7yIqi9WJv5V4K2tXt7t-FWD1jZbqdhd2DDl3fhejfC8vwe2K9LPY9ZW_FOo7N8zZqKIapk-H-6DXFR_JFVBdMl04tq0VT1vA7RyyfkiitUZFZRJJjNS7agj1AQ_jJL2rhklFeo78P0Klj8ALbKqvSPgKXcOi-90VaakfPaKKGlRdBpUmeziAfwbuBpbvum5jRb4yRvk-uJylsR5CSCXCD5mxX5ouvmcRnhSxTQioZ6cI93Jzn9Rg3KON5q3-MAtgf55f3Jr_PfehrAi9UynllimC59dUY0GU3aSUUWALuERglkpUQwH8DDTiNWu-FxkqJ9UwHINV1Z2-76Sjk_bluHI2DhyUgG8HbQqj92_i9GPP7_Oz6HG-Pp4SSf7B8dPIGbXWkFFeBtw1azPPNPEbE15ll7ThjkV3wufwG621iF |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB61qUBcEG9cCiyIxwUr8TrrXR8QKrRRSkuoUJF6s_ZlNRKy0zgF9afx75jxIxBKufWaHTnrmdndb2c-zwC8ME4r7dIUnVfzcGiGmvK7aag9T2weUxc4ind8miTjr8OPx-J4DX5238IQrbLbE-uN2pWWYuT9SCqqoiq46OctLeJwZ_RudhpSBynKtHbtNBoX2ffnP_D6Vr3d20Fbv-R8tHv0YRy2HQZCK_hgEZqIe2ki43yeDLi3CI6ESYTQCV4kci-5SZTHlzRcOrybuEilRuZOKq8cHrwxPnYdNiRdinqw8X53cvhlGeAZxDHhibau5yBWfUsMoYZNJvjKObh-QizMixD3IlPzr3RtfQqObsHNFr6y7cbfbsOaL-7Ataah5fldsJ_nehqxmv9OjbR8xRYlQ4zJ8P90HfCiaCQrc6YLpmflbFFW0yrEOz_hWBwhyllJcWE2LdiMPklBMMws-eacUZahugdHV6Hk-9ArysI_BJZw67z0Rltphs5ro4SWFiGoSZxNBzyAN51OM9uWOKdOG9-yOtUeq6w2QUYmyASKv1qKz5raHpcJPkcDLWWoIvd4-yCj36hcGcc97nsUwFZnv6zdB6rst9cG8Gw5jCuYFKYLX56RTEp9dxKRBsAukVECVSkR2gfwoPGI5Wx4FCd42qkA5IqvrEx3daSYntSFxBG-8HgoA3jdedUfM_-XIjb__45P4Tquyexgb7L_CG40PAti421BbzE_848Rvi3Mk3ahMMiueGn-AlFfXiA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Orai1+contributes+to+the+establishment+of+an+apoptosis-resistant+phenotype+in+prostate+cancer+cells&rft.jtitle=Cell+death+%26+disease&rft.au=Flourakis%2C+M&rft.au=Lehen%27Kyi%2C+V&rft.au=Beck%2C+B&rft.au=Rapha%C3%ABl%2C+M&rft.date=2010-09-01&rft.pub=Nature+Publishing+Group&rft.issn=2041-4889&rft.eissn=2041-4889&rft.volume=1&rft.issue=9&rft.spage=e75&rft.epage=e75&rft_id=info:doi/10.1038%2Fcddis.2010.52&rft_id=info%3Apmid%2F21364678&rft.externalDBID=HAS_PDF_LINK&rft.externalDocID=oai_HAL_hal_04122793v1 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2041-4889&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2041-4889&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2041-4889&client=summon |